Product Code: ETC340803 | Publication Date: Aug 2022 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 | |
The pneumonia vaccine market in Mexico is expanding due to public health initiatives and increasing awareness of vaccine-preventable diseases. Pneumonia vaccines protect against bacterial and viral infections that cause pneumonia, improving population health and reducing healthcare costs.
Public health initiatives, vaccination programs, and efforts to reduce pneumonia-related morbidity and mortality drive the Mexico Pneumonia Vaccine market. Pneumonia vaccines protect against bacterial and viral pathogens, preventing respiratory infections and associated complications, thus contributing to improved health outcomes and reduced healthcare burden in Mexico.
Challenges involve ensuring vaccine efficacy and safety, addressing vaccine distribution and storage requirements, and managing vaccination coverage rates to prevent pneumonia outbreaks.
Government policies in Mexico for the pneumonia vaccine market focus on public health, disease prevention, and immunization coverage. These policies encompass regulations for vaccine safety and efficacy, guidelines for vaccination schedules and administration, and incentives for vaccine research and development.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Mexico Pneumonia Vaccine Market Overview |
3.1 Mexico Country Macro Economic Indicators |
3.2 Mexico Pneumonia Vaccine Market Revenues & Volume, 2021 & 2031F |
3.3 Mexico Pneumonia Vaccine Market - Industry Life Cycle |
3.4 Mexico Pneumonia Vaccine Market - Porter's Five Forces |
3.5 Mexico Pneumonia Vaccine Market Revenues & Volume Share, By Vaccine Type, 2021 & 2031F |
3.6 Mexico Pneumonia Vaccine Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.7 Mexico Pneumonia Vaccine Market Revenues & Volume Share, By Sector, 2021 & 2031F |
3.8 Mexico Pneumonia Vaccine Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Mexico Pneumonia Vaccine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about the importance of vaccination for pneumonia prevention |
4.2.2 Government initiatives and campaigns promoting vaccination programs |
4.2.3 Rising incidences of pneumonia cases in Mexico |
4.3 Market Restraints |
4.3.1 High cost of pneumonia vaccines leading to affordability issues |
4.3.2 Limited access to healthcare services in remote or rural areas |
4.3.3 Potential side effects associated with pneumonia vaccines |
5 Mexico Pneumonia Vaccine Market Trends |
6 Mexico Pneumonia Vaccine Market, By Types |
6.1 Mexico Pneumonia Vaccine Market, By Vaccine Type |
6.1.1 Overview and Analysis |
6.1.2 Mexico Pneumonia Vaccine Market Revenues & Volume, By Vaccine Type, 2021-2031F |
6.1.3 Mexico Pneumonia Vaccine Market Revenues & Volume, By Pneumococcal Conjugate Vaccine, 2021-2031F |
6.1.4 Mexico Pneumonia Vaccine Market Revenues & Volume, By Pneumococcal Polysaccharide Vaccine, 2021-2031F |
6.2 Mexico Pneumonia Vaccine Market, By Product Type |
6.2.1 Overview and Analysis |
6.2.2 Mexico Pneumonia Vaccine Market Revenues & Volume, By Prevnar 13, 2021-2031F |
6.2.3 Mexico Pneumonia Vaccine Market Revenues & Volume, By Synflorix, 2021-2031F |
6.2.4 Mexico Pneumonia Vaccine Market Revenues & Volume, By Pneumovax 23, 2021-2031F |
6.3 Mexico Pneumonia Vaccine Market, By Sector |
6.3.1 Overview and Analysis |
6.3.2 Mexico Pneumonia Vaccine Market Revenues & Volume, By Public, 2021-2031F |
6.3.3 Mexico Pneumonia Vaccine Market Revenues & Volume, By Private, 2021-2031F |
6.4 Mexico Pneumonia Vaccine Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 Mexico Pneumonia Vaccine Market Revenues & Volume, By Distribution Partner Companies, 2021-2031F |
6.4.3 Mexico Pneumonia Vaccine Market Revenues & Volume, By Non-governmental Organizations (NGO), 2021-2031F |
6.4.4 Mexico Pneumonia Vaccine Market Revenues & Volume, By Government Authorities, 2021-2031F |
7 Mexico Pneumonia Vaccine Market Import-Export Trade Statistics |
7.1 Mexico Pneumonia Vaccine Market Export to Major Countries |
7.2 Mexico Pneumonia Vaccine Market Imports from Major Countries |
8 Mexico Pneumonia Vaccine Market Key Performance Indicators |
8.1 Percentage increase in vaccination coverage rates among the population |
8.2 Number of government-funded pneumonia vaccination campaigns conducted annually |
8.3 Rate of pneumonia cases reported and treated in healthcare facilities |
9 Mexico Pneumonia Vaccine Market - Opportunity Assessment |
9.1 Mexico Pneumonia Vaccine Market Opportunity Assessment, By Vaccine Type, 2021 & 2031F |
9.2 Mexico Pneumonia Vaccine Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.3 Mexico Pneumonia Vaccine Market Opportunity Assessment, By Sector, 2021 & 2031F |
9.4 Mexico Pneumonia Vaccine Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Mexico Pneumonia Vaccine Market - Competitive Landscape |
10.1 Mexico Pneumonia Vaccine Market Revenue Share, By Companies, 2024 |
10.2 Mexico Pneumonia Vaccine Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |